Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...

Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...

The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing ...

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, ...

Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product ...

Thermo Fisher is acquiring Sanofi’s Ridgefield, NJ sterile drug plant, transferring 200 employees to bolster U.S. fill‑finish ...

Thermo Fisher Scientific (TMO) recently unveiled two new electron microscopes, Scios 3 and Talos 12, at the Microscopy & Microanalysis conference, reinforcing their advanced technology offerings. The ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

Two major names in the biopharma industry are announcing a new deal to boost drug product manufacturing in the U.S.

Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...

Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Thermo Fisher (TMO – Research Report) and Sanofi (SNYNF – Research Report) with bullish sentiments.